Divi's Lab.

{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "6,817.00",
    "chg": -70,
    "chgp": "-1.02%",
    "dir": -1,
    "prev_price": "6,887.00",
    "mcapval": "180,969.93 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE361B01024",
    "curr_date": "May 25",
    "curr_time": "",
    "bse_nse_vol": "6.61 lacs",
    "exc_status": "Active",
    "traded_date": "May 25, 2026",
    "traded_date_str": "2026 05 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Divis Laboratories Upgraded to Buy on Strong Technical and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-upgraded-to-buy-on-strong-technical-and-financial-performance-4010057",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_mojoScore_4010057.png",
        "date": "2026-05-25 08:04:50",
        "description": "Divis Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, announced on 23 May 2026, follows a robust quarter and sustained market outperformance, positioning the pharmaceutical giant favourably amid sector peers."
      },
      {
        "title": "Are Divis Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-divis-laboratories-ltd-latest-results-good-or-bad-4009602",
        "imagepath": "",
        "date": "2026-05-24 19:13:04",
        "description": "Divi's Laboratories Ltd has reported its financial results for Q4 FY26, showcasing notable operational trends. The company achieved a consolidated net profit of ₹751 crores, reflecting a year-on-year growth of 13.44% compared to Q4 FY25, and a sequential increase of 28.82% from Q3 FY26. This marks the highest quarterly net profit recorded by the company, indicating strong profitability momentum.\n\nIn terms of revenue, net sales reached ₹2,831 crores, representing an 8.72% increase quarter-on-quarter and a 9.52% growth year-on-year. This robust sales performance highlights strengthening demand dynamics in Divi's core active pharmaceutical ingredient (API) business, which serves a diverse international market.\n\nHowever, the operating margin, excluding other income, was reported at 32.99%, down from 34.27% in the previous year, suggesting some pressure on operational efficiency despite the overall profit growth..."
      },
      {
        "title": "Divi's Laboratories Q4 FY26: Strong Profit Surge Masks Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/divis-laboratories-q4-fy26-strong-profit-surge-masks-valuation-concerns-4008887",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_quaterlyResult_4008887.png",
        "date": "2026-05-23 17:45:53",
        "description": "Divi's Laboratories Ltd., India's second-largest pharmaceutical company by market capitalisation, reported a robust performance for Q4 FY26, with net profit surging 28.82% quarter-on-quarter to ₹751.00 crores, marking the highest quarterly profit in the company's recent history. The stock, currently trading at ₹6,885.00, has gained 0.36% in the trading session following the results announcement, reflecting investor optimism about the company's operational momentum."
      },
      {
        "title": "Divis Laboratories Gains 1.83%: 4 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-183-4-key-factors-driving-the-weeks-momentum-4008752",
        "imagepath": "",
        "date": "2026-05-23 17:06:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> Stock opens at Rs.6,833.05 with a 1.06% gain despite Sensex decline</p>\n                    <p><strong>19 May:</strong> Golden Cross formation signals potential bullish breakout; Mojo Grade upgraded to Hold</p>\n                    <p><strong>20 May:</strong> Technical momentum shifts to bullish with strong MACD and Bollinger Bands</p>\n                    <p><strong>22 May:</strong> Sharp open interest surge in derivatives market amid price recovery</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,833.05</div></div>\n                    <..."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-bullish-market-positioning-4005493",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_oi_spurts_by_underlying_4005493.png",
        "date": "2026-05-22 15:00:30",
        "description": "Divis Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical giant’s stock has outperformed its sector peers, supported by robust volume patterns and improved investor sentiment, as it trades near its 52-week high."
      },
      {
        "title": "Divis Laboratories Sees Significant Open Interest Surge Amid Positive Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-significant-open-interest-surge-amid-positive-market-momentum-4005390",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_oi_spurts_by_underlying_4005390.png",
        "date": "2026-05-22 14:00:23",
        "description": "Divis Laboratories Ltd, a large-cap leader in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market activity and potential directional bets. The stock’s recent performance, combined with evolving volume patterns and positioning shifts, offers valuable insights for investors navigating this dynamic phase."
      },
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-4000096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_technicaldot_4000096.png",
        "date": "2026-05-20 08:01:52",
        "description": "Divis Laboratories Ltd has exhibited a notable shift in price momentum, transitioning from a sideways trend to a bullish stance, supported by a range of technical indicators. This change has prompted an upgrade in its MarketsMOJO grade from Sell to Hold, reflecting improved investor sentiment and technical strength in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Golden Cross Confirmed: Do Divis Laboratories Ltd's Other Technical Indicators Agree?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3999496",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_goldencross_3999496.png",
        "date": "2026-05-19 18:00:16",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Divis Laboratories Ltd, signalling a golden cross on 19 Jun 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a nuanced picture that merits closer examination."
      },
      {
        "title": "Divis Laboratories Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-upgraded-to-hold-by-marketsmojo-on-improved-technicals-and-financials-3998258",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_mojoScore_3998258.png",
        "date": "2026-05-19 08:16:58",
        "description": "Divis Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across multiple key parameters including quality, valuation, financial trends, and technical indicators. This shift comes amid strong quarterly financials, robust long-term returns, and a stabilising technical outlook, signalling a more balanced risk-reward profile for investors."
      }
    ],
    "total": 635,
    "sid": "509760",
    "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "details": "Divi's Laboratories Limited has informed the Exchange regarding Disclosure of Related Party Transaction under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Divi's Laboratories Limited - Other General Purpose",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Divi's Laboratories Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Divi's Laboratories Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Divi's Laboratories Limited has informed the Exchange regarding 'US-FDA Inspection of Unit -I at village Lingojigudem, Bhuvanagiri Yadadri District, Telangana'.",
      "source": "NSE",
      "caption": "Divi's Laboratories Limited - Updates",
      "datetime": "15-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Divis Laboratories Upgraded to Buy on Strong Technical and Financial Performance

2026-05-25 08:04:50

Divis Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, announced on 23 May 2026, follows a robust quarter and sustained market outperformance, positioning the pharmaceutical giant favourably amid sector peers.

Read full news article

Are Divis Laboratories Ltd latest results good or bad?

2026-05-24 19:13:04

Divi's Laboratories Ltd has reported its financial results for Q4 FY26, showcasing notable operational trends. The company achieved a consolidated net profit of ₹751 crores, reflecting a year-on-year growth of 13.44% compared to Q4 FY25, and a sequential increase of 28.82% from Q3 FY26. This marks the highest quarterly net profit recorded by the company, indicating strong profitability momentum. In terms of revenue, net sales reached ₹2,831 crores, representing an 8.72% increase quarter-on-quarter and a 9.52% growth year-on-year. This robust sales performance highlights strengthening demand dynamics in Divi's core active pharmaceutical ingredient (API) business, which serves a diverse international market. However, the operating margin, excluding other income, was reported at 32.99%, down from 34.27% in the previous year, suggesting some pressure on operational efficiency despite the overall profit growth...

Read full news article

Divi's Laboratories Q4 FY26: Strong Profit Surge Masks Valuation Concerns

2026-05-23 17:45:53

Divi's Laboratories Ltd., India's second-largest pharmaceutical company by market capitalisation, reported a robust performance for Q4 FY26, with net profit surging 28.82% quarter-on-quarter to ₹751.00 crores, marking the highest quarterly profit in the company's recent history. The stock, currently trading at ₹6,885.00, has gained 0.36% in the trading session following the results announcement, reflecting investor optimism about the company's operational momentum.

Read full news article

Divis Laboratories Gains 1.83%: 4 Key Factors Driving the Week’s Momentum

2026-05-23 17:06:59

Key Events This Week

18 May: Stock opens at Rs.6,833.05 with a 1.06% gain despite Sensex decline

19 May: Golden Cross formation signals potential bullish breakout; Mojo Grade upgraded to Hold

20 May: Technical momentum shifts to bullish with strong MACD and Bollinger Bands

22 May: Sharp open interest surge in derivatives market amid price recovery

Week Open

Rs.6,833.05

<...

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning

2026-05-22 15:00:30

Divis Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical giant’s stock has outperformed its sector peers, supported by robust volume patterns and improved investor sentiment, as it trades near its 52-week high.

Read full news article

Divis Laboratories Sees Significant Open Interest Surge Amid Positive Market Momentum

2026-05-22 14:00:23

Divis Laboratories Ltd, a large-cap leader in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market activity and potential directional bets. The stock’s recent performance, combined with evolving volume patterns and positioning shifts, offers valuable insights for investors navigating this dynamic phase.

Read full news article

Divis Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-05-20 08:01:52

Divis Laboratories Ltd has exhibited a notable shift in price momentum, transitioning from a sideways trend to a bullish stance, supported by a range of technical indicators. This change has prompted an upgrade in its MarketsMOJO grade from Sell to Hold, reflecting improved investor sentiment and technical strength in the Pharmaceuticals & Biotechnology sector.

Read full news article

Golden Cross Confirmed: Do Divis Laboratories Ltd's Other Technical Indicators Agree?

2026-05-19 18:00:16

The 50-day moving average has crossed above the 200-day moving average for Divis Laboratories Ltd, signalling a golden cross on 19 Jun 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a nuanced picture that merits closer examination.

Read full news article

Divis Laboratories Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financials

2026-05-19 08:16:58

Divis Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across multiple key parameters including quality, valuation, financial trends, and technical indicators. This shift comes amid strong quarterly financials, robust long-term returns, and a stabilising technical outlook, signalling a more balanced risk-reward profile for investors.

Read full news article

View All News